SRPT

SEC source: 0001209191-21-018418 · doc4.xml · derivative · entry 2

MARTIN JOHN C · CIK 0001190578 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,518

Underlying: Common Stock · 5,518 shares

Expires 2031-03-03

SEC source: 0001209191-21-018418 · doc4.xml · nonDerivative · entry 1

MARTIN JOHN C · CIK 0001190578 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,913

F1 · price: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 3, 2022.

SEC source: 0001209191-21-018417 · doc4.xml · derivative · entry 2

GRAY MARY ANN · CIK 0001261974 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,518

Underlying: Common Stock · 5,518 shares

Expires 2031-03-03

SEC source: 0001209191-21-018417 · doc4.xml · nonDerivative · entry 1

GRAY MARY ANN · CIK 0001261974 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,436

F1 · price: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 3, 2022.

SEC source: 0001209191-21-018416 · doc4.xml · derivative · entry 2

Estepan Ian Michael · CIK 0001836254 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2031-03-03

F2 · derivative.exercise_date: Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter.

SEC source: 0001209191-21-018416 · doc4.xml · nonDerivative · entry 1

Estepan Ian Michael · CIK 0001836254 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,042

F1 · price: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest and become exercisable on the first anniversary of the grant date, and additional 25% will vest and become exercisable on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested and exercisable on the fourth anniversary of the grant date.

SEC source: 0001209191-21-018415 · doc4.xml · derivative · entry 2

Ciambrone William · CIK 0001794135 · EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2031-03-03

F2 · derivative.exercise_date: Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter.

SEC source: 0001209191-21-018415 · doc4.xml · nonDerivative · entry 1

Ciambrone William · CIK 0001794135 · EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

F1 · price: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest and become exercisable on the first anniversary of the grant date, and additional 25% will vest and become exercisable on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested and exercisable on the fourth anniversary of the grant date.

SEC source: 0001209191-21-018414 · doc4.xml · derivative · entry 2

Brown Ryan Edward · CIK 0001848718 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2031-03-03

F2 · derivative.exercise_date: Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter.

SEC source: 0001209191-21-018414 · doc4.xml · nonDerivative · entry 1

Brown Ryan Edward · CIK 0001848718 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,838

F1 · price: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest and become exercisable on the first anniversary of the grant date, and additional 25% will vest and become exercisable on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested and exercisable on the fourth anniversary of the grant date.

SEC source: 0001209191-21-018413 · doc4.xml · derivative · entry 2

Barry Richard · CIK 0001562371 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,518

Underlying: Common Stock · 5,518 shares

Expires 2031-03-03

SEC source: 0001209191-21-018413 · doc4.xml · nonDerivative · entry 1

Barry Richard · CIK 0001562371 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,125,366

F1 · price: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 3, 2022.

SEC source: 0001209191-21-018412 · doc4.xml · derivative · entry 3

BEHRENS M KATHLEEN · CIK 0001211701 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,518

Underlying: Common Stock · 5,518 shares

Expires 2031-03-03

SEC source: 0001209191-21-018412 · doc4.xml · nonDerivative · entry 1

BEHRENS M KATHLEEN · CIK 0001211701 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,517

F1 · price: The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 3, 2022.

F2 · balance_after: Reflects a correction in the number of shares of common stock reported as beneficially owned by the Reporting Person in prior reports due to an inadvertent error that appeared in the prior reports (an addition of 49 shares).

SEC source: 0001209191-21-019668 · doc4a.xml · nonDerivative · entry 2

O'Neill Gilmore Neil · CIK 0001742084 · EVP, R&D & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,546

F2 · balance_after: On March 5, 2021, the Form 4 filed for the reporting person overstated the number of shares held by the reporting person. This amended form corrects such error by reporting the number of shares withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units on February 28, 2021 and by reporting the corrected total amount of securities directly owned by the reporting person following a grant of restricted stock units on March 3, 2021.

SEC source: 0001209191-21-019667 · doc4a.xml · nonDerivative · entry 2

Brown Ryan Edward · CIK 0001848718 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,622

F2 · balance_after: On March 5, 2021, the Form 4 filed for the reporting person overstated the number of shares held by the reporting person. This amended form corrects such error by reporting the number of shares withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units on February 28, 2021 and by reporting the corrected total amount of securities directly owned by the reporting person following a grant of restricted stock units on March 3, 2021.

SEC source: 0001209191-21-019666 · doc4a.xml · nonDerivative · entry 2

Rodino-Klapac Louise · CIK 0001836218 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,780

F2 · balance_after: On March 5, 2021, the Form 4 filed for the reporting person overstated the number of shares held by the reporting person. This amended form corrects such error by reporting the number of shares withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units on February 28, 2021 and by reporting the corrected total amount of securities directly owned by the reporting person following a grant of restricted stock units on March 3, 2021.

F3 · balance_after: The amount of securities directly owned by the reporting person includes 176 shares of common stock purchased under the Company's Amended and Restated 2013 Employee Stock Purchase Plan on February 28, 2021.

SEC source: 0001209191-21-019664 · doc4a.xml · nonDerivative · entry 2

Estepan Ian Michael · CIK 0001836254 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,723

F2 · balance_after: On March 5, 2021, the Form 4 filed for the reporting person overstated the number of shares held by the reporting person. This amended form corrects such error by reporting the number of shares withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units on February 28, 2021 and by reporting the corrected total amount of securities directly owned by the reporting person following a grant of restricted stock units on March 3, 2021.

SEC source: 0001209191-21-019668 · doc4a.xml · nonDerivative · entry 1

O'Neill Gilmore Neil · CIK 0001742084 · EVP, R&D & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,546

F1 · kind: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on February 28, 2020.

F2 · balance_after: On March 5, 2021, the Form 4 filed for the reporting person overstated the number of shares held by the reporting person. This amended form corrects such error by reporting the number of shares withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units on February 28, 2021 and by reporting the corrected total amount of securities directly owned by the reporting person following a grant of restricted stock units on March 3, 2021.

SEC source: 0001209191-21-019667 · doc4a.xml · nonDerivative · entry 1

Brown Ryan Edward · CIK 0001848718 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,622

F1 · kind: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on February 28, 2020.

F2 · balance_after: On March 5, 2021, the Form 4 filed for the reporting person overstated the number of shares held by the reporting person. This amended form corrects such error by reporting the number of shares withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units on February 28, 2021 and by reporting the corrected total amount of securities directly owned by the reporting person following a grant of restricted stock units on March 3, 2021.

SEC source: 0001209191-21-019666 · doc4a.xml · nonDerivative · entry 1

Rodino-Klapac Louise · CIK 0001836218 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,604

F1 · kind: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on February 28, 2020.

F2 · balance_after: On March 5, 2021, the Form 4 filed for the reporting person overstated the number of shares held by the reporting person. This amended form corrects such error by reporting the number of shares withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units on February 28, 2021 and by reporting the corrected total amount of securities directly owned by the reporting person following a grant of restricted stock units on March 3, 2021.

SEC source: 0001209191-21-019664 · doc4a.xml · nonDerivative · entry 1

Estepan Ian Michael · CIK 0001836254 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,723

F1 · kind: Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on February 28, 2020.

F2 · balance_after: On March 5, 2021, the Form 4 filed for the reporting person overstated the number of shares held by the reporting person. This amended form corrects such error by reporting the number of shares withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units on February 28, 2021 and by reporting the corrected total amount of securities directly owned by the reporting person following a grant of restricted stock units on March 3, 2021.

SEC source: 0001209191-21-000556 · doc4.xml · nonDerivative · entry 1

INGRAM DOUGLAS S · CIK 0001190644 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 357,868

F1 · kind: Shares were withheld by the Company to satisfy tax withholding obligations related to a vesting of a restricted stock award granted on June 26, 2017.

F1 · shares: Shares were withheld by the Company to satisfy tax withholding obligations related to a vesting of a restricted stock award granted on June 26, 2017.

F1 · acquired: Shares were withheld by the Company to satisfy tax withholding obligations related to a vesting of a restricted stock award granted on June 26, 2017.

SEC source: 0001209191-20-063360 · doc4.xml · derivative · entry 1

Rodino-Klapac Louise · CIK 0001836218 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2030-12-14

F1 · derivative.exercise_date: Twenty-five percent of the shares of common stock underlying the option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares of common stock underlying such option shall vest and become exercisable on each monthly anniversary of such date of grant thereafter, such that the option will be fully vested and exercisable on the fourth anniversary of the date of grant.

SEC source: 0001209191-20-063359 · doc4.xml · derivative · entry 1

Estepan Ian Michael · CIK 0001836254 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2030-12-14

F1 · derivative.exercise_date: Twenty-five percent of the shares of common stock underlying the option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares of common stock underlying such option shall vest and become exercisable on each monthly anniversary of such date of grant thereafter, such that the option will be fully vested and exercisable on the fourth anniversary of the date of grant.

SEC source: 0001209191-20-063355 · doc4.xml · derivative · entry 3

Bratica Joseph · CIK 0001820070 · Principal Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,285

Underlying: Common Stock · 1,115 shares

Expires 2028-03-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction.

SEC source: 0001209191-20-063355 · doc4.xml · nonDerivative · entry 2

Bratica Joseph · CIK 0001820070 · Principal Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,140

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction.

SEC source: 0001209191-20-063355 · doc4.xml · nonDerivative · entry 1

Bratica Joseph · CIK 0001820070 · Principal Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,255

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction.

SEC source: 0001209191-20-062809 · doc4.xml · derivative · entry 2

GRAY MARY ANN · CIK 0001261974 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 967

Underlying: Common Stock · 967 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Sarepta Therapeutics, Inc. common stock.

F2 · derivative.exercise_date: The second out of three annual equal installments of restricted stock units vested on December 10, 2020.

F2 · derivative.expiration_date: The second out of three annual equal installments of restricted stock units vested on December 10, 2020.

SEC source: 0001209191-20-062809 · doc4.xml · nonDerivative · entry 1

GRAY MARY ANN · CIK 0001261974 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,710

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Sarepta Therapeutics, Inc. common stock.

SEC source: 0001209191-20-062807 · doc4.xml · derivative · entry 3

Bratica Joseph · CIK 0001820070 · Principal Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,500

Underlying: Common Stock · 1,125 shares

Expires 2027-03-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction.

SEC source: 0001209191-20-062807 · doc4.xml · nonDerivative · entry 2

Bratica Joseph · CIK 0001820070 · Principal Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,140

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction.

SEC source: 0001209191-20-062807 · doc4.xml · nonDerivative · entry 1

Bratica Joseph · CIK 0001820070 · Principal Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,265

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction.

F2 · balance_after: Amount of Securities Beneficially Owned includes 308 shares purchased under the Company's registered Employee Stock Purchase Plan on August 31, 2020.

SEC source: 0001209191-20-046251 · doc4.xml · derivative · entry 4

Wigzell Hans Lennart Rudolf · CIK 0001492766 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2023-06-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-20-046251 · doc4.xml · nonDerivative · entry 3

Wigzell Hans Lennart Rudolf · CIK 0001492766 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,792

F2 · price: The shares were sold in transactions at prices ranging from 159.47 to 159.90, inclusive. The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001209191-20-046251 · doc4.xml · nonDerivative · entry 2

Wigzell Hans Lennart Rudolf · CIK 0001492766 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,569

F1 · price: The shares were sold in transactions at prices ranging from 158.45 to 159.36, inclusive. The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001209191-20-046251 · doc4.xml · nonDerivative · entry 1

Wigzell Hans Lennart Rudolf · CIK 0001492766 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,792

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-010478 · doc5.xml · nonDerivative · entry 1

Barry Richard · CIK 0001562371 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,122,640

F1 · price: Represents a charitable donation to an educational institution.

SEC source: 0001209191-20-045774 · doc4.xml · nonDerivative · entry 2

Barry Richard · CIK 0001562371 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,129,140

F2 · price: The shares were sold in transactions at prices ranging from $159.01 to $159.17, inclusive. The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001209191-20-045774 · doc4.xml · nonDerivative · entry 1

Barry Richard · CIK 0001562371 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,132,280

F1 · price: The shares were sold in transactions at prices ranging from $158.00 to $159.00, inclusive. The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

SEC source: 0001209191-20-045321 · doc4.xml · derivative · entry 3

Bratica Joseph · CIK 0001820070 · Principal Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,625

Underlying: Common Stock · 1,125 shares

Expires 2027-03-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction.

SEC source: 0001209191-20-045321 · doc4.xml · nonDerivative · entry 2

Bratica Joseph · CIK 0001820070 · Principal Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,832

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction.

SEC source: 0001209191-20-045321 · doc4.xml · nonDerivative · entry 1

Bratica Joseph · CIK 0001820070 · Principal Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,957

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction.

SEC source: 0001209191-20-042060 · doc4.xml · derivative · entry 8

Mahatme Sandesh · CIK 0001511034 · EVP, CFO & CBO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,203 shares

Expires 2027-03-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-20-042060 · doc4.xml · derivative · entry 7

Mahatme Sandesh · CIK 0001511034 · EVP, CFO & CBO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 218 shares

Expires 2026-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-20-042060 · doc4.xml · derivative · entry 6

Mahatme Sandesh · CIK 0001511034 · EVP, CFO & CBO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,385 shares

Expires 2026-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-20-042060 · doc4.xml · nonDerivative · entry 4

Mahatme Sandesh · CIK 0001511034 · EVP, CFO & CBO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,260

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-20-042060 · doc4.xml · nonDerivative · entry 3

Mahatme Sandesh · CIK 0001511034 · EVP, CFO & CBO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,057

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-20-042060 · doc4.xml · nonDerivative · entry 2

Mahatme Sandesh · CIK 0001511034 · EVP, CFO & CBO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,839

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-20-038339 · doc4.xml · derivative · entry 12

Howton David T · CIK 0001529297 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,708

Underlying: Common Stock · 45,000 shares

Expires 2024-02-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction.